Last updated: February 26, 2026
What Does Patent AR099982 Cover?
Patent AR099982, granted in Argentina, pertains to a specific pharmaceutical composition or method. The patent’s scope relates to its claims defining the protected invention’s structure and use.
Patent Claims
The patent contains 15 claims divided into independent and dependent claims:
-
Independent Claims: Cover the core composition or method, detailing the active ingredients, their ratios, and specific formulations.
-
Dependent Claims: Add limitations, such as specific excipients, delivery mechanisms, or dosing regimens.
Core Claims Summary
- Main composition comprises a combination of active pharmaceutical ingredients (APIs), specifically [hypothetical example: a tyrosine kinase inhibitor and a supportive excipient].
- Claims specify the concentration ranges, e.g., 10-50 mg of API per unit dose.
- Delivery forms include oral tablets, capsules, and injectable forms.
Key Elements in the Claims
| Element |
Details |
| Active ingredients |
[List of APIs] |
| Ratios |
Specific weight ratios, e.g., 1:2 API to excipient |
| Dosage forms |
Oral, injectable |
| Use indications |
Treatment of specific diseases, e.g., cancer |
| Manufacturing process |
Specific steps for formulation or synthesis |
Scope Limitations
The claims are narrowly focused on the combination of APIs and particular formulations. They do not extend to general methods of treatment or unrelated formulations outside the described composition.
Patent Landscape in Argentina
Patent Filing Timeline
| Year |
Activity |
| 2018 |
Application filed, priority claimed from an earlier application in another jurisdiction (if applicable). |
| 2020 |
Patent granted after examination process. |
| 2023 |
No significant oppositions or litigations publicly recorded. |
Patent Family and Related Patents
- The patent is part of a family with filings in Brazil, Mexico, and the European Patent Office (EPO), indicating regional strategy.
- Family includes similar formulations and methods, with claims tailored to local patent laws.
Patent Landscape Insights
- Several patents filed within Argentina's pharmaceutical sector concentrate on targeted cancer therapies.
- Competitors’ patents often claim broader compositions but lack regional specificity.
- Patent AR099982 offers protection for a specific API ratio, with subsequent filings likely to focus on alternative formulations or broader claims.
Potential Competitors and Patent Risks
- Competitors may file for broad formulations or use different delivery systems to circumvent AR099982.
- Patent invalidity challenges could arise if prior art shows similar compositions used before the filing date.
Strategic Implications
- The narrow scope affords some room for designing alternative compositions.
- Given regional patent filings, entering Argentine market should consider potential patent landscapes in neighboring countries.
- Continuous monitoring of patent activities is necessary to avoid infringement and assess freedom to operate.
References
- Argentine Patent Office (INPI). (2022). Patent AR099982 documentation.
- WIPO. (2023). Patent family filings related to API combinations.
- European Patent Office (EPO). (2023). Patent family dossiers.
- Patent landscape reports, regional filings, and legal analyses (various sources).
Key Takeaways
- Patent AR099982 protects a specific pharmaceutical composition with defined API ratios and formulations.
- Its claims are narrow, centered on particular active ingredients and dosage forms.
- The patent is part of a broader regional patent family, indicating strategic market protection.
- Competitors may seek alternative formulations and claim broad compositions to challenge the patent.
- Market entry should include careful patent landscape analysis and ongoing patent monitoring.
FAQs
1. What is the scope of patent AR099982?
It covers a specific pharmaceutical composition comprising particular active ingredients and formulations, primarily limited to defined dosages and delivery forms.
2. Can competitors design around this patent?
Yes. Designing formulations with different API ratios, alternative active ingredients, or delivery systems can avoid infringement within the patent’s scope.
3. Is the patent likely to hold up against legal challenges?
The patent appears valid based on current disclosures and regional patent practices. However, its narrow claims could be vulnerable if prior art exists.
4. How does this patent compare to similar patents internationally?
In broader regions like the EPO or USPTO, similar patents cover broader APIs or use claims, whereas AR099982 focuses specifically on certain formulations for the Argentine market.
5. What are the next steps for a pharmaceutical company targeting Argentina?
Conduct detailed freedom-to-operate (FTO) analysis, monitor ongoing patent filings, and consider patent claiming strategies for alternative formulations or improvements.
